Grail, Inc. (NASDAQ:GRAL) CFO Aaron Freidin Sells 1,816 Shares of Stock

Grail, Inc. (NASDAQ:GRAL) CFO Aaron Freidin sold 1,816 shares of the stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $56,659.20. Following the completion of the transaction, the chief financial officer now owns 335,170 shares of the company’s stock, valued at $10,457,304. The trade was a 0.54 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Grail Price Performance

NASDAQ GRAL opened at $30.85 on Thursday. The firm has a 50 day simple moving average of $31.42 and a 200-day simple moving average of $21.15. Grail, Inc. has a one year low of $12.33 and a one year high of $63.99.

Grail (NASDAQ:GRAL) last issued its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, beating the consensus estimate of ($4.41) by $2.55. The business had revenue of $38.25 million during the quarter, compared to analysts’ expectations of $35.33 million. Equities research analysts expect that Grail, Inc. will post -15.15 earnings per share for the current year.

Institutional Investors Weigh In On Grail

Several large investors have recently bought and sold shares of the stock. FNY Investment Advisers LLC purchased a new position in shares of Grail in the 4th quarter valued at about $26,000. Lindbrook Capital LLC acquired a new stake in Grail in the fourth quarter valued at approximately $28,000. State of Tennessee Department of Treasury purchased a new position in Grail in the fourth quarter worth approximately $28,000. Sterling Capital Management LLC purchased a new position in Grail in the fourth quarter worth approximately $29,000. Finally, Wellington Shields Capital Management LLC acquired a new position in Grail during the 4th quarter worth approximately $33,000.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the company. Morgan Stanley initiated coverage on Grail in a report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 price target for the company. Wolfe Research began coverage on shares of Grail in a research report on Friday, November 15th. They set a “peer perform” rating for the company.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.